Concourse Financial Group Securities’s Franklin Genomic Advancements ETF HELX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Hold |
0
| – | – | – | 3561 |
|
|
2024
Q4 | – | Hold |
0
| – | – | – | 4897 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 4881 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 4918 |
|
|
2024
Q1 | – | Hold |
0
| – | – | – | 4921 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 4862 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 4788 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 4720 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 4586 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 4560 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 4364 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 4396 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 4327 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 4390 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 4295 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 4174 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 4078 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 3982 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 3822 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 3713 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 3717 |
|